A thorough market landscape review is instrumental to ensure market access for your project by analysing and defining the potential market opportunities as well as any barriers.
This will enable you to clarify your objectives and to define a strategy that will increase your chances of successful market entry.
An outcome of a market landscape review is strategy for pricing and market access that supports the objective of your market entry.
This will serve as a current market overview and a future scenario analysis.
A market landscape review gathers important information, such as:
Competitor intelligence
Country-specific pricing and reimbursement needs
Clinical guidelines
Payer positions
Unmet need
Current policies
The review will form the basis for strategy recommendations such as:
– Market access strategy
– Pricing strategy
– HEOR (Health Economic Outcomes Research) evidence generation plan
– Value proposition
– Payer/stakeholder engagement plan
– Market access route
Early market access strategy
HTA/reimbursement submission strategy
Susanne Schuurman
Staffan Thunell
Founding partner
BSc Economics and BA
Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from positions as Founder, Chairman, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.
